NSETrading Window6h ago · 25 Sept 2026, 01:18 pm
Trading Window
IOL Chemicals and Pharmaceuticals Limited · IOLCP
✦ AI Summary
IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in the securities of the Company shall remain closed for all Designated Persons and their Immediate Relatives from 1st October 2026 until the expiry of 48 hours after the declaration of the financial results for the quarter and half year ended 30th September 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
IOLCP_25092026131743_Intimation25N.pdf
View document text
25th September 2026
IOLCP/CGC/2026
National Stock Exchange of India Ltd. BSE Limited
Exchange Plaza, Plot no. C/1, G Block, Phiroze Jeejeebhoy Towers,
Bandra-Kurla Complex, Bandra (E) Dalal Street
Mumbai - 400 051 Mumbai – 400 001
Security Symbol: IOLCP Security Code: 524164
Subject: Intimation of Closure of Trading Window
Dear Sir,
Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as
amended, and the Company’s “Code of Conduct to Regulate, Monitor and Report Trading by
Designated Persons”, the Trading Window for dealing in the securities of the Company shall
remain closed for all Designated Persons and their Immediate Relatives with effect from
1st October 2026 and shall remain closed until the expiry of 48 hours after the declaration of
the financial results of the Company for the quarter and half year ended 30th September 2026.
The date of the meeting of the Board of Directors for consideration and approval of the
aforesaid financial results will be intimated to the Stock Exchanges in due course.
This is for information and record please.
Thanking You,
Yours faithfully,
for IOL Chemicals and Pharmaceuticals Limited
Abhay Raj Singh
Sr. Vice President & Company Secretary